| Metric | FY 2010 | Prior Q | FY 2009 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $162M | — | $0 | — | — |
| Op. Income | $162M | — | $193M | — | -15.7% |
| Gross Margin | 100.0% | — | — | — | — |
| Net Margin | 82.7% | — | — | — | — |
| EPS (Diluted) | $1.31 | — | $1.80 | — | -27.2% |
| Free Cash Flow | $151M | — | -$27M | — | 659.7% |
| Item | Amount |
|---|---|
| REVENUE | $162M |
| Cost of Revenue | $0 |
| GROSS PROFIT | $162M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $0 |
| Operating Expenses | $0 |
| Cost & Expenses | $0 |
| OPERATING INCOME | $162M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $162M |
| Income Tax Expense | $28M |
| Net Income from Continuing Ops | $134M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $134M |
| Net Income Deductions | -$2M |
| BOTTOM LINE NET INCOME | $136M |
| D&A | $0 |
| EBIT | $162M |
| EBITDA | $162M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $162M |
| Cost of Revenue | $0 |
| GROSS PROFIT | $162M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $0 |
| Other Expenses | $0 |
| Operating Expenses | $0 |
| Cost & Expenses | $0 |
| OPERATING INCOME | $162M |
| Interest Income | $0 |
| Interest Expense | $0 |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $162M |
| Income Tax Expense | $28M |
| Net Income from Continuing Ops | $134M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $134M |
| Net Income Deductions | -$2M |
| BOTTOM LINE NET INCOME | $136M |
| D&A | $0 |
| EBIT | $162M |
| EBITDA | $162M |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $134M |
| Depreciation & Amortization | $47M |
| Stock-Based Compensation | $123M |
| Deferred Income Tax | -$332M |
| Other Non-Cash Items | $182M |
| Change in Working Capital | -$3M |
| OPERATING CASH FLOW | $151M |
| Capital Expenditure | $0 |
| Acquisitions (Net) | $0 |
| Purchases of Investments | -$8M |
| Sales/Maturities of Investments | $4M |
| Other Investing Activities | -$4M |
| NET CASH FROM INVESTING | -$8M |
| Net Debt Issuance | $0 |
| Common Stock Repurchased | $0 |
| Common Dividends Paid | -$151M |
| Other Financing Activities | $8M |
| NET CASH FROM FINANCING | -$143M |
| FREE CASH FLOW | $151M |
| Net Change in Cash | $36M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $0 |
| Short-Term Investments | $0 |
| Net Receivables | $1M |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $1M |
| PP&E (Net) | $0 |
| Goodwill | $0 |
| Intangible Assets | $0 |
| Long-Term Investments | $1.8B |
| Tax Assets | $0 |
| Other Non-Current Assets | $0 |
| TOTAL NON-CURRENT ASSETS | $1.8B |
| TOTAL ASSETS | $1.8B |
| Account Payables | $0 |
| Short-Term Debt | $0 |
| Deferred Revenue | $0 |
| Other Current Liabilities | $0 |
| TOTAL CURRENT LIABILITIES | $0 |
| Long-Term Debt | $0 |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $458.0K |
| TOTAL NON-CURRENT LIABILITIES | $458.0K |
| TOTAL LIABILITIES | $458.0K |
| Common Stock | $0 |
| Additional Paid-In Capital | $0 |
| Retained Earnings | $0 |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $0 |
| Other Equity | $1.8B |
| TOTAL STOCKHOLDERS' EQUITY | $1.8B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.8B |
| TOTAL LIABILITIES & EQUITY | $1.8B |
| Total Debt | $0 |
| Net Debt | $0 |
